青岛地区6-丙酮酰四氢生物蝶呤缺乏症患儿基因变异特点及随访分析

doi:10.12372/jcp.2023.22e1473

摘要/Abstract

摘要：

目的探讨青岛地区6-丙酮酰四氢蝶呤合成酶缺乏症（PTPSD）筛查情况、临床表现、基因变异情况及长期随访结果。方法对1996年11月至2021年12月经新生儿筛查确诊的251例高苯丙氨酸血症（HPA）患儿进行尿蝶呤谱检测、红细胞二氢蝶呤还原酶活性检测、四氢生物蝶呤（BH4）负荷试验及基因检测以确诊PTPSD，进一步分析青岛市PTPSD的发生率、基因变异特点及长期随访结果。结果 251例HPA患儿中，26例诊断为四氢生物蝶呤缺乏症（2对单卵双胞胎、1对为非同胎生姐妹），均为PTPSD，发病率为12.7/100万（双胎按1例计算）。19例患儿（来自17个家庭）进行基因检测，PTPS的34个等位基因中共检测出10种变异，变异频率较高的为c.259C>T（29.4%，10/34），其余依次为c.286G>A（14.7%，5/34）、c.272A>G（14.7%，5/34）、c.84-291A>G（8.8%，3/34）、c.166G>A(8.8%，3/34)、c.276T>A (8.8%，3/34)，变异位点主要集中在5号外显子67.6%（23/34）。其中c.200C>T、c.259C>T、c.286G>A可能导致严重型PTPSD。结论 1996－2021年青岛地区PTPSD发生率为12.7/100万，PTPS基因的热点突变为c.259C>T、c.286G>A、c.272A>G。建立完善的新生儿疾病筛查-诊断-治疗-长期随访-救助的一体化管理体系是作好出生缺陷第三级预防，降低残疾儿发生的有力措施。

关键词: 高苯丙氨酸血症, 四氢生物蝶呤缺乏症, 6-丙酮酰四氢蝶呤合成酶, 基因突变

Abstract:

Objective To investigate the screening, clinical manifestations, genetic variants and long-term follow-up results of 6-pyruvoyltetrahydropterin synthase deficiency (PTPSD) in Qingdao. Methods Two hundred and fifty-one children with hyperphenylalaninemia (HPA) in Qingdao Women and Children's Hospital from November 1998 to December 2021 were included, and urinary pterin profile test, erythrocyte dihydropteroate reductase activity test, tetrahydrobiopterin (BH4) loading test, and genetic test were performed to confirm the diagnosis of PTPSD. The incidence, gene mutations and long-term follow-up of PTPSD were analyzed. Results Twenty-six children were diagnosed as tetrahydrobioptenin deficiency (BH4D), all PTPSD, and the incidence of PTPSD among newborns in Qingdao was 12.7 per million. 19 children (from 17 families) underwent genetic testing, and 10 variants were detected among 34 alleles of PTS, with the higher frequency of variants being c.259C>T (29.4%, 10/34), and the rest were c.286G>A (14.7%, 5/34), c.272A>G (14.7%, 5/34), c.84-291A>G (8.8%, 3/34), c.166G>A (8.8%, 3/34), c.276T>A (8.8%, 3/34 ), and the variant sites were mainly concentrated in exon 5 (67.6%, 23/34). Among them, c.200C>T, c.259C>T and c.286G>A may be associated with severe PTPSD. Conclusion The incidence of PTPSD in Qingdao is 12.7/ million in 1996-2021, and the hotspot variants of PTS gene are c.259C>T, c.286G>A, c.272A>G. Establishment of a complete integrated management system of newborn disease screening-diagnosis-treatment-long-term follow-up-assistance is a powerful measure to achieve a tertiary prevention of birth defects and reduce the occurrence of disabled children.

Key words: hyperphenylalaninemia, tetrahydrobiopterin deficiency, 6-pyruvyl tetrahydrotrexate synthetase deficiency, gene variation

钟瑶瑶, 张立琴, 杜玮, 陆薇冰, 刘婷廷. 青岛地区6-丙酮酰四氢生物蝶呤缺乏症患儿基因变异特点及随访分析[J]. 临床儿科杂志, 2023, 41(2): 103-107.

ZHONG Yaoyao, ZHANG Liqin, DU Wei, LU Weibing, LIU Tingting. Gene mutation analysis and long-term follow-up of 6-pyruvoyltetrahydropterin synthase deficiency in Qingdao[J]. Journal of Clinical Pediatrics, 2023, 41(2): 103-107.

图/表 2

表1

表2

参考文献 20

[1]	van Spronsen FJ, Blau N, Harding C, et al. Phenylketonuria[J]. Nat Rev Dis Primers, 2021, 7(1): 36. doi: 10.1038/s41572-021-00267-0 pmid: 34017006
[2]	Opladen T, López-Laso E, Cortès-Saladelafont E, et al. Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies[J]. Orphanet J Rare Dis, 2020, 15(1): 126. doi: 10.1186/s13023-020-01379-8 pmid: 32456656
[3]	Elhawary NA, AlJahdali IA, Abumansour IS, et al. Genetic etiology and clinical challenges of phenylketonuria[J]. Hum Genomics, 2022, 16(1): 22. doi: 10.1186/s40246-022-00398-9 pmid: 35854334
[4]	中华医学会儿科学分会内分泌遗传代谢学组,中华预防医学会中华预防医学会出生缺陷预防与控制专业. 高苯丙氨酸血症的诊治共识[J]. 中华儿科杂志, 2014, 52(6): 420-425.
[5]	张立琴, 何怡峰, 宋扬, 等. 四氢生物蝶呤缺乏症7例早期临床诊断及治疗[J]. 中国儿童保健杂志, 2005, 13(2): 127-128.
[6]	Moammar H, Cheriyan G, Mathew R, et al. Incidence and patterns of inborn errors of metabolism in the Eastern Province of Saudi Arabia, 1983-2008 [J]. Ann Saudi Med, 2010, 30(4): 271-277. doi: 10.4103/0256-4947.65254 pmid: 20622343
[7]	Khatami S, Dehnabeh SR, Zeinali S, et al. Four years of diagnostic challenges with tetrahydrobiopterin deficiencies in Iranian patients[J]. JIMD Rep, 2017, 32: 7-14. doi: 10.1007/8904_2016_572 pmid: 27246466
[8]	陈挺, 赵正言, 蒋萍萍, 等. 高苯丙氨酸血症表型与基因型研究进展[J]. 浙江大学学报(医学版), 2018, 47(3): 219-226.
[9]	吕书博, 赵德华, 张琳琳, 等. 河南地区6-丙酮酰四氢蝶呤合成酶缺乏症基因变异分析[J]. 中华实用儿科临床杂志, 2020, 35(9): 691-694.
[10]	Yuan X, Zhu J, Liu H, et al. Birth prevalence of tetrahydrobiopterin deficiency in China: data from the national newborn screening program, 2013-2019 [J]. J Pediatr Endocrinol Metab, 2021, 34(7): 835-841. doi: 10.1515/jpem-2021-0077 pmid: 33838095
[11]	Ye J, Yang Y, Yu W, et al. Demographics, diagnosis and treatment of 256 patients with tetrahydrobiopterin deficiency in mainland China: results of a retrospective, multicentre study[J]. J Inherit Metab Dis, 2013, 36(5): 893-901. doi: 10.1007/s10545-012-9550-6 pmid: 23138986
[12]	Li N, Yu P, Rao B, et al. Molecular genetics of tetrahydrobiopterin deficiency in Chinese patients[J]. J Pediatr Endocrinol Metab, 2018, 31(8): 911-916. doi: 10.1515/jpem-2018-0037 pmid: 30001213
[13]	Thöny B, Blau N. Mutations in the BH4-metabolizing genes GTP cyclohydrolase I, 6-pyruvoyl-tetrahydropterin synthase, sepiapterin reductase, carbinolamine-4a- dehydratase, and dihydropteridine reductase[J]. Hum Mutat, 2006, 27(9): 870-878. doi: 10.1002/humu.20366 pmid: 16917893
[14]	Oppliger T, Thöny B, Kluge C, et al. Identification of mutations causing 6-pyruvoyl-tetrahydropterin synthase deficiency in four Italian families[J]. Hum Mutat, 1997, 10(1): 25-35. pmid: 9222757
[15]	Imamura T, Okano Y, Shintaku H, et al. Molecular characterization of 6-pyruvoyl-tetrahydropterin synthase deficiency in Japanese patients[J]. J Hum Genet, 1999, 44(3): 163-168. doi: 10.1007/s100380050134 pmid: 10319579
[16]	Liu TT, Chiang SH, Wu SJ, et al. Tetrahydrobiopterin-deficient hyperphenylalaninemia in the Chinese[J]. Clin Chim Acta, 2001, 313(1-2): 157-169. pmid: 11694255
[17]	Manti F, Nardecchia F, Banderali G, et al. Long-term clinical outcome of 6-pyruvoyl-tetrahydropterin synthase-deficient patients[J]. Mol Genet Metab, 2020, 131(1-2): 155-162. doi: 10.1016/j.ymgme.2020.06.009 pmid: 32651154
[18]	Chiu YH, Chang YC, Chang YH, et al. Mutation spectrum of and founder effects affecting the PTS gene in East Asian populations[J]. J Hum Genet, 2012, 57(2): 145-152. doi: 10.1038/jhg.2011.146
[19]	Li L, Yang H, Zhao J, et al. Identification and molecular analysis of 11 cases of the PTS gene variants associated with tetrahydrobiopterin deficiency[J]. Front Genet, 2022, 13: 919209. doi: 10.3389/fgene.2022.919209
[20]	Himmelreich N, Blau N, Thöny B. Molecular and metabolic bases of tetrahydrobiopterin (BH4) deficiencies[J]. Mol Genet Metab, 2021, 133(2): 123-136. doi: 10.1016/j.ymgme.2021.04.003

编号	碱基改变	氨基酸改变	位点	变异频率	比例/%
1	c.34G>C	p.Ala12Pro	E1	1	2.94
2	c.155A>G	p.Asn 52Ser	E2	1	2.94
3	c.166G>A	p.Val56Met	E3	3	8.82
4	c.200C>T	p.Thr67Met	E4	2	5.88
5	c.259C>T	p.Pro87 Ser	E5	10	29.41
6	c.272A>G	p.Lys91Arg	E5	5	14.70
7	c.276T>A	p.Asn92 Lys	E5	3	8.82
8	c.286G>A	p.Asp96Asn	E5	5	14.70
9	c.317C>T	p.Thr106Met	E6	1	2.94
10	c.84-291A>G	IVS1-291A>G	I1	3	8.82